Newron Pharmaceuticals S.p.A. Stock CBOE EUROPE EQUITIES
Stocks
0QOI
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
||
| 12.30 CHF | -2.07% |
|
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 272M 315M 254M 233M 439M 29.96B 446M 2.98B 1.17B 15.01B 1.18B 1.16B 49.64B | P/E 2026 * |
-9.64x | P/E 2027 * | 35.4x |
|---|---|---|---|---|---|
| Enterprise Value | 311M 359M 290M 266M 501M 34.21B 509M 3.41B 1.34B 17.15B 1.35B 1.32B 56.69B | EV / Sales 2026 * |
28.7x | EV / Sales 2027 * | 6.4x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Newron Pharmaceuticals S.p.A.
| 1 week | +3.89% | ||
| Current month | +3.89% | ||
| 1 month | +2.67% | ||
| 3 months | -10.35% | ||
| 6 months | -34.99% | ||
| Current year | -48.32% |
| 1 week | 11.5 |  | 12.66 |
| 1 month | 11.32 | | 12.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.07% | 0.00% | - | - | 315M | |
| +0.99% | +1.78% | +4.07% | +16.73% | 49.47B | |
| +3.71% | +9.40% | +486.98% | +592.14% | 43.61B | |
| +5.60% | +10.21% | +16.76% | +85.72% | 39.6B | |
| +2.70% | +1.57% | +33.39% | +8.85% | 39.29B | |
| +2.21% | +6.75% | +21.31% | +53.37% | 32.43B | |
| +2.23% | +4.71% | - | - | 16.84B | |
| +0.97% | +2.35% | +37.75% | +126.84% | 16.49B | |
| -0.11% | +2.41% | +6.24% | +18.87% | 14.01B | |
| +0.75% | +15.04% | +78.59% | +30.30% | 12.77B | |
| Average | +2.12% | +6.32% | +85.64% | +116.60% | 29.39B | |
| Weighted average by Cap. | +2.54% | +6.10% | +104.25% | +140.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.54M 10.13M 9.29M 17.47M 1.19B 17.75M 119M 46.63M 598M 47.07M 46.04M 1.98B | 44.83M 51.83M 41.86M 38.4M 72.23M 4.93B 73.38M 491M 193M 2.47B 195M 190M 8.17B |
| Net income | -31.17M -36.04M -29.11M -26.71M -50.23M -3.43B -51.03M -342M -134M -1.72B -135M -132M -5.68B | 5.02M 5.81M 4.69M 4.3M 8.09M 553M 8.22M 55.04M 21.6M 277M 21.81M 21.33M 916M |
| Net Debt | 38.68M 44.72M 36.13M 33.14M 62.33M 4.26B 63.32M 424M 166M 2.13B 168M 164M 7.05B | 14.72M 17.01M 13.74M 12.61M 23.71M 1.62B 24.09M 161M 63.29M 812M 63.89M 62.49M 2.68B |
Employees
-
Calendar
| Date | Price | Change |
|---|---|---|
| 26-08-07 | CHF 12.30 | -2.07% |
| 26-08-06 | CHF 12.56 | +2.11% |
| 26-08-05 | CHF 12.30 | +4.24% |
| 26-08-04 | CHF 11.80 | +0.68% |
| 26-08-03 | CHF 11.72 | -1.01% |
- Stock Market
- Stocks
- NWRN Stock
- 0QOI Stock
Select your edition
All financial news and data tailored to specific country editions
